The proposed bill aims to address offenses related to xylazine by amending existing Florida statutes. It introduces new criminal penalties for individuals who sell, manufacture, deliver, or possess xylazine with the intent to sell, manufacture, or deliver. Specifically, the bill adds xylazine to the list of controlled substances under section 893.13, making it a first-degree felony with a mandatory minimum sentence of three years for violations. Additionally, the bill establishes a new offense of "trafficking in xylazine" under section 893.135, which imposes severe penalties based on the quantity involved, including mandatory minimum sentences ranging from seven to twenty-five years and fines from $50,000 to $500,000.

The bill also outlines the specific penalties for trafficking in xylazine, categorizing offenses based on the amount possessed. For example, possessing 4 grams or more but less than 14 grams results in a minimum sentence of seven years, while 28 grams or more incurs a minimum of 25 years. The legislation is set to take effect on October 1, 2025, reflecting a significant step in Florida's efforts to combat the growing concerns surrounding the misuse of xylazine and its impact on public health and safety.

Statutes affected:
H 57 Filed: 893.13, 893.135